TrialBlood2015

Clinical and pharmacodynamic analysis of pomalidomide dosing strategies in myeloma: impact of immune activation and cereblon targets.

Kartik Sehgal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.